Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of SU011248 Plus Irinotecan in the Treatment of Patients With Malignant Glioma

NCT00611728 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT00611728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00611728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of SU011248 Plus Irinotecan in the Treatment of Patients With Malignant Glioma
Lead sponsor
Duke University
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2008
Completion date
September 30, 2010
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma